Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemia

Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemia - Effect of anagliptin on lipid profile

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013878

Enrollment

Registered

2014-05-12

Start date

2014-05-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabeteic patients with hyperlipidemia

Exclusion criteria

Exclusion criteria: Patients with severe renal disfunction Patients with severe liver disfunction Pregnant or lactating patients Patients with obstruction of the intestines Patients with pancreatitis

Design outcomes

Primary

Measure	Time frame
LDL-cholesterol	—

Countries

Japan

Contacts

Public ContactKazutaka Aoki

Yokohama City University Hospital Department of Biostatistics and Epidemiology

aokikazu@yokohama-cu.ac.jp045-787-2800

Outcome results